CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis.

Jamal, Muhammad; Lei, Yufei; He, Hengjing; Zeng, Xingruo; Bangash, Hina Iqbal; Xiao, Di; Shao, Liang; Zhou, Fuling; Zhang, Quiping

Jamal, Muhammad; Lei, Yufei; He, Hengjing; Zeng, Xingruo; Bangash, Hina Iqbal; Xiao, Di; Shao, Liang; Zhou, Fuling; Zhang, Quiping.

Afiliación

Jamal M; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Lei Y; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
He H; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Zeng X; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Bangash HI; State Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Xiao D; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Shao L; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhou F; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhang Q; Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.

Front Pharmacol ; 14: 1257289, 2023.

Article en En | MEDLINE | ID: mdl-37745085

Palabras clave

CCR9; RNA-sequencing; SREBF2; T-ALL; cholesterol biosynthesis; simvastatin; tissue infiltration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google